Varicella vaccination--a critical review of the evidence.
作者信息
Skull S A, Wang E E
机构信息
Department of Pediatrics, The Hospital for Sick Children and University of Toronto, Canada.
出版信息
Arch Dis Child. 2001 Aug;85(2):83-90. doi: 10.1136/adc.85.2.83.
Abstract
摘要
相似文献
1
Varicella vaccination--a critical review of the evidence.
Arch Dis Child. 2001 Aug;85(2):83-90. doi: 10.1136/adc.85.2.83.
2
[Varicella vaccine].
Arch Pediatr. 1999 Sep;6(9):1005-9. doi: 10.1016/s0929-693x(99)80597-1.
3
Varicella zoster vaccines.
Dermatol Ther. 2009 Mar-Apr;22(2):143-9. doi: 10.1111/j.1529-8019.2009.01226.x.
4
Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.
Med Microbiol Immunol. 2002 Oct;191(2):89-96. doi: 10.1007/s00430-002-0123-4. Epub 2002 Aug 29.
5
Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.
EBioMedicine. 2015 Aug 8;2(10):1494-9. doi: 10.1016/j.ebiom.2015.08.017. eCollection 2015 Oct.
6
Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised cases.
Vaccine. 2008 Oct 16;26(44):5619-26. doi: 10.1016/j.vaccine.2008.07.096. Epub 2008 Aug 22.
7
Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination.
Southeast Asian J Trop Med Public Health. 2004 Sep;35(3):693-6.
8
Cost-effectiveness analysis of varicella vaccine as post-exposure prophylaxis in Hong Kong.
Scand J Infect Dis. 2014 Jan;46(1):27-33. doi: 10.3109/00365548.2013.847529. Epub 2013 Nov 15.
9
[Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
Rev Epidemiol Sante Publique. 2008 Oct;56(5):323-31. doi: 10.1016/j.respe.2008.07.087. Epub 2008 Oct 31.
10
[Economical effectiveness of vaccination of cohort of children aged 2 years against chickenpox in the Russian Federation].
Zh Mikrobiol Epidemiol Immunobiol. 2012 May-Jun(3):43-50.
引用本文的文献
1
Clinical efficacy and effectiveness of alternative varicella vaccination strategies: An overview of reviews.
Rev Med Virol. 2023 Jan;33(1):e2407. doi: 10.1002/rmv.2407. Epub 2022 Nov 15.
2
Hospitalization for acute cerebellitis in children affected by varicella: how much does it cost?
Ital J Pediatr. 2020 Aug 6;46(1):114. doi: 10.1186/s13052-020-00875-8.
3
Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-blind, randomized study.
BMC Pediatr. 2019 Feb 7;19(1):50. doi: 10.1186/s12887-019-1425-7.
4
Safety, immunogenicity, and lot-to-lot consistency of live attenuated varicella vaccine in 1-3 years old children: a double-blind, randomized phase III trial.
Hum Vaccin Immunother. 2019;15(4):822-827. doi: 10.1080/21645515.2018.1551701. Epub 2019 Jan 24.
5
Microbiology laboratory and the management of mother-child varicella-zoster virus infection.
World J Virol. 2016 Aug 12;5(3):97-124. doi: 10.5501/wjv.v5.i3.97.
6
Varicella vaccine without human serum albumin versus licensed varicella vaccine in children during the second year of life: a randomized, double-blind, non-inferiority trial.
BMC Pediatr. 2016 Jan 13;16:7. doi: 10.1186/s12887-016-0546-5.
7
The impact of ten years of infant universal Varicella vaccination in Sicily, Italy (2003-2012).
Hum Vaccin Immunother. 2015;11(1):236-9. doi: 10.4161/hv.36157. Epub 2014 Nov 1.
8
Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.
Cochrane Database Syst Rev. 2014 Jun 23;2014(6):CD001833. doi: 10.1002/14651858.CD001833.pub3.
9
Chickenpox.
BMJ Clin Evid. 2011 Apr 11;2011:0912.
10
Chickenpox.
BMJ Clin Evid. 2007 Aug 1;2007:0912.
本文引用的文献
1
THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS.
Proc R Soc Med. 1965 Jan;58(1):9-20. doi: 10.1177/003591576505800106.
2
Randomized controlled trial of physiotherapy in 56 children with cerebral palsy followed for 18 months.
Dev Med Child Neurol. 2001 Jan;43(1):4-15. doi: 10.1017/s0012162201000020.
3
Postlicensure safety surveillance for varicella vaccine.
JAMA. 2000 Sep 13;284(10):1271-9. doi: 10.1001/jama.284.10.1271.
4
Cost effectiveness of vaccination strategies in adults without a history of chickenpox.
Am J Med. 2000 Jun 15;108(9):723-9. doi: 10.1016/s0002-9343(00)00445-9.
5
Chickenpox attributable to a vaccine virus contracted from a vaccinee with zoster.
Pediatrics. 2000 Aug;106(2):E28. doi: 10.1542/peds.106.2.e28.
6
Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes.
Vaccine. 2000 Jun 15;18(25):2775-8. doi: 10.1016/s0264-410x(00)00100-6.
7
Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children.
Nat Med. 2000 Apr;6(4):451-4. doi: 10.1038/74715.
8
Experience with live attenuated varicella vaccine (Oka strain) in healthy Japanese subjects; 10-year survey at pediatric clinic.
Vaccine. 2000 May 8;18(22):2375-80. doi: 10.1016/s0264-410x(00)00016-5.
9
Immunology of Varicella Immunization in the elderly.
Ann Pharmacother. 2000 Feb;34(2):228-34. doi: 10.1345/aph.19121.
10
Postlicensure study of varicella vaccine effectiveness in a day-care setting.
Pediatr Infect Dis J. 1999 Dec;18(12):1047-50. doi: 10.1097/00006454-199912000-00004.
Zotero 插件